Results 131 to 140 of about 40,698 (218)

In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolates. [PDF]

J Antimicrob Chemother
Patterson-Fahy K, Carter R, Bell SC, Evans IES, Burke AJ, Thomson RM.   +5 more
europepmc   +1 more source

Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam Against Metallo-β-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-based model. [PDF]

J Infect Dis
Arun B, Liu E, Vallé Q, Sharma R, Bui NM, Mezcord V, Luu I, Traglia GM, Pasteran F, Paterson D, Bonomo RA, Ramirez MS, Rao GG.   +12 more
europepmc   +1 more source

Fitz Hugh Curtis Case Report [PDF]

, 2020
Bitter, Cindy, Loehr, Savannah
core  

Comparative effectiveness of ertapenem versus other empirical antibiotics in elderly patients with complicated intra-abdominal infection: a real-world inverse probability of treatment weighting study. [PDF]

Front Cell Infect Microbiol
Sun Y, Guo Y, Cui H, Jiang Y, Yu Q.
europepmc   +1 more source

Antibacterial activity of enmetazobactam against <i>Acinetobacter</i> spp.: a molecular dissection of mechanism of action and resistance determinants. [PDF]

Antimicrob Agents Chemother
Báez-Barroso G-A, Rodríguez-Coello A, Vázquez-Ucha JC, López-Argüello S, Outeda-García M, González-Pinto L, García-Pose A, Guijarro-Sánchez P, Alonso-García I, Lence E, González-Bello C, Oliver A, Arca-Suárez J, Moya B, Bou G, Beceiro A, Spanish National Acinetobacter spp. 2020 Study Group.   +16 more
europepmc   +1 more source

Correlation between antimicrobial susceptibility data and clinical efficacy for <i>Helicobacter cinaedi</i> bacteraemia. [PDF]

JAC Antimicrob Resist
Araoka H, Tomida J, Yoshino C, Baba M, Ogura S, Kimura M, Kawamura Y.   +6 more
europepmc   +1 more source

Critical Analysis of Fixed-Dose Antibiotic Combinations Sold in Kinshasa-Democratic Republic of the Congo. [PDF]

Antibiotics (Basel)
Mankulu JK, Ive DK, Kasago FM, Mpuya EM, Mfuamba BK, Mufusama Koy Sita JP, Ciza Hamuli P, Kimbeni Malongo T, Mbinze Kindenge J, Liesse Iyamba JM, Mana Kialengila D.   +10 more
europepmc   +1 more source

Evaluation of sulbactam/durlobactam activity and synergy against highly drug-resistant <i>Acinetobacter baumannii</i> strains. [PDF]

JAC Antimicrob Resist
Halim J, Bouzo J, Carabetta VJ.
europepmc   +1 more source

Comparative effectiveness of two antimicrobial regimens for the treatment of pan-drug-resistant <i>Acinetobacter baumannii</i> infections: results from the DESPAIR study. [PDF]

Antimicrob Agents Chemother
Pontikis K, Karaiskos I, Sakagianni A, Mouloudi E, Tsigou E, Gkoufa A, Michelidou S, Mouratidou K, Gavala A, Routsi C, Karakonstantis S, Michalea S, Ampelioti S, Katsarou T, Papathanasiou A, Pirounaki M, Anastogiannis C, Koutsoukou A, Giamarellou H, Daikos GL, DESPAIR Study Group.   +20 more
europepmc   +1 more source